Daewon Pharmaceutical Company Limited (003220) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Daewon Pharmaceutical Company Limited Company Snapshot

Business Description:

Daewon Pharmaceutical Company Limited operates in the Medicinals and botanicals sector. Daewon Pharmaceutical Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company's products include respiratory drugs, gastrointestinal drugs, antimicrobial drugs, cardiovascular drugs, metabolic drugs, psychoneurotic drugs, neuromuscular drugs, endocrine drugs and others. The Company also produces multivitamins and health foods. The Company offers its products in the type of tablet, film-coated tablet, sugar-coated tablet, hard capsule, soft capsule, pouch, bottle, vial and ampoule. The Company distributes its products within domestic market and overseas markets, including Southeast Asia, Latin America and the Middle East, which are covered by 25 countries. In our complete report available for purchase the company is compared to: Dongkook Pharmaceutical Company Limited, IL-Yang Pharmaceutical Company Limited and Pacific Pharmaceutical Co., Ltd..

Daewon Pharmaceutical Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 7,000.00
(Figures in Korean Won)

1 Week	2.8%	13 Weeks	35.1%

4 Weeks	40.5%	52 Weeks	11.1%

Daewon Pharmaceutical Company Limited Key Data:

Ticker:	003220	Country:	KOREA (SOUTH)

Exchanges:	SEO	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	144,696,109,000 (Year Ending Jan 2011).	Employees:	488

Currency:	Korean Won	Market Cap:	98,235,398,800

Fiscal Yr Ends:	December	Shares Outstanding:	14,033,628

Share Type:	Common	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.